High incidence of rheumatic fever and Rheumatic heart disease in the republics of Central Asia

International Journal of Rheumatic Diseases

Volumn 12, Issue 2, 2009, Pages 79-83

  Omurzakova, Nazgul A ^a,c   Yamano, Yoshihisa ^a   Saatova, Guli M ^c   Mirzakhanova, Mavliuda I ^e   Shukurova, Surayo M ^f   Kydyralieva, Ryskul B ^c   Jumagulova, Aynagul S ^c   Seisenbaev, Askar Sh ^g   Nishioka, Kusuki ^a   Nakajima, Toshihiro ^b,d  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Fukushimura Hospital   (Japan)

^c Ministry of Health of the Kyrgyz Republic   (Kyrgyzstan)

^d Misato Marine Hospital   (Japan)

^e TASHKENT MEDICAL ACADEMY   (Uzbekistan)

^f Tajik Institute of Postgraduate Training of Medical Professionals   (Tajikistan)

^g ASFENDIYAROV KAZAKH NATIONAL MEDICAL UNIVERSITY   (Kazakhstan)

Author keywords

Central Asia; Group A haemolytic streptococci; Rheumatic fever; Rheumatic heart disease

Indexed keywords

AFRICA; ANTIBIOTIC SENSITIVITY; ARTICLE; ASIA; AUSTRALIA; BACTERIAL VIRULENCE; CENTRAL ASIA; COMPARATIVE STUDY; DEVELOPING COUNTRY; DISEASE CONTROL; GROUP A STREPTOCOCCAL INFECTION; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; INCIDENCE; INFECTION PREVENTION; ISCHEMIC HEART DISEASE; JAPAN; KYRGYZSTAN; MORTALITY; NEW ZEALAND; PEDIATRICS; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; RURAL AREA; SOCIAL STATUS; STATISTICS; STREPTOCOCCUS PYOGENES; UNITED STATES; USSR;

HUMANS; INCIDENCE; KYRGYZSTAN; PREVALENCE; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; RISK FACTORS;

EID: 67749120593     PISSN: 17561841     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2009.01388.x     Document Type: Article

References (27)

1. Dajani AS, Bisno AI, Chung KJ, et al. (1988) Prevention of Rheumatic fever. A statement for health professionals by the Committee on Rheumatic fever. Endocarditis, Kawasaki Dis Counc Cardiovasc Dis Young, Am Heart Assoc//Ciculation 78, 1082-6.
2. Bisno AL, Gerber MA, Gwaltney JM, Kaplan EL, Schwartz RH (2002) Infectious diseases society of America. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis 15, 113-25.
3. Stollerman GH (1971) Rheumatogenic, Nephritogenic Streptococci. Circulation 43, 915-21.
4. Bisno AL, Brito MO, Collins CM (2003) Molecular basis of group A streptococcal virulence. Lancet Infect Dis 3, 191-200.
5. Kaplan EL (1993) Global assessment of Rheumatic fever and Rheumatic Heart disease at the Clouse of the Century. Influences and Dynamics of Populations and Pathogens: A failure to Realize Prevention? Circulation 88, 1964-1972.
6. Allan Gibofsky, Zabriskie John B (2001) Rheumatic fever: Etiology, diagnosis, and treatment. Arthritis and allied conditions. A textbook of Rheumatology, 14th edn. William J Koopman 2, 1486, 1761-73.
7. Swedo SE, Leonard HL, Garvey M, et.al. (1998) Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of first 50 cases. Am J Psychiatry 155, 264-71.
8. Murphy ML, Pichichero ME (2002) Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Arch Pediatr Adolesc Med 156, 356-61.
9. Voroncov IM (2003) Rheumatic fever at children: Old and new. The actual topic. Rus. Medical scientifically-practical journal' Doctor in charge' #2. http://www.lvrach.ru/.
10. National Statistic Committee report (2007-2008). http://www.stat.kg/.
11. Nazgul AO, Yoshihisa Y, Tomoo S, et al. (2008) Increased prevalence of group A b-hemolytic streptococcus among an ethnic population in Kyrgyzstan detected by the rapid antigen detection test. Mol Med Rep 1, 869-74.
12. Rheumatic fever and RHD (29 October-1 November 2001) Report of a WHO Expert Consultation, Geneva.
13. Carapetis JR, Steer AC, Mulholland EK, Weber M (2005) The global burden of group A streptococcal diseases. Lancet Infect Dis 5, 685-94.
14. American Heart Association (2009) Retrieved on (2009)-03-04. 'Rheumatic Heart Disease Statistics'http://www.americanheart.org/ presenter.jhtml?identifier=4712.
15. Kawakita S (1986) Rheumatic fever and Rheumatic Heart Disease in Japan. Jap Circ J 50 (12), 1241-5.
16. Atlas of Heart Diseases and Stroke (2004) Available from URL. http://www.who.int/cardivascular_diseases/resources/atlas/en/ Rheumaticfeverandrheumaticheartdisease.
17. Rheumatic fever and rheumatic heart disease (2004) report of a WHO expert consultation. World Health Organ Tech Rep 923, 1-122.
18. Jonathan RC (2007) Rheumatic heart disease in developing countries. N Engl JM 357, 439-41.
19. Spencer RC (1995) Invasive streptococci. Eur J Clin Microbiol Infect Dis 14, S26-S32.
20. Stevens DL (1996) Invasive group A streptococcal disease. Infect Agents Dis 5 (3), 157-66.
21. Efstratiou A (2000) Group A streptococci in the 1990s. J Antimicrob Chemother 45 (suppl.), 3-12.
22. Abu-Sabaah AH, Ghazi HO (2006) Better diagnosis and treatment of throat infections caused by group A beta-haemolytic streptococci. Br J Biomed Sci 63 (4), 155-8. Links.
23. Schwartz B, Marcy M, Phillips WR, Gerber MA, Dowell SF (1998) Pharyngitis: Principles of judicious use of antimicrobial agents. Pediatrics 101, 171-4.
24. Miyake CY, Gauvreau K, Tani LY, et.al. (2007) Characteristics of children discharged from hospitals in the United States in 2000 with the diagnosis of acute rheumatic fever. Pediatrics 120, 503.
25. Shulman ST, Stollerman G, Beall B, et.al. (2006) Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States. Clin Infect Dis 42, 441.
26. Johnson DR, Stevens DL, Kaplan EL (1992) Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 166, 374.
27. Erdem G, Mizumoto C, Esaki D, et al. (2007) Group A streptococcal isolates temporally associated with acute rheumatic fever in Hawaii: Differences from the continental United States. Clin Infect Dis 45, e20.